Monogram Orthopaedics (NASDAQ:MGRM) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Monogram Orthopaedics (NASDAQ:MGRM) posted its earnings results on Wednesday. The company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Trading Up 2.2 %

Shares of NASDAQ:MGRM traded up $0.05 on Wednesday, hitting $2.32. 42,960 shares of the company were exchanged, compared to its average volume of 42,627. The firm has a market capitalization of $79.60 million, a P/E ratio of -4.94 and a beta of 1.66. Monogram Orthopaedics has a 1-year low of $1.53 and a 1-year high of $4.90. The stock’s 50 day moving average price is $2.54 and its 200 day moving average price is $2.50.

Analyst Ratings Changes

Several analysts have recently commented on the company. Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 price objective for the company. Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.